US Drug Recall Register
Class III · Low risk Terminated Initiated Feb 9, 2024 (3 years ago)

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b)…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications: results slightly under spec at at 9-months.

What was recalled

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

Recalling firm
Stason Pharmaceuticals, Inc.
NDC code
69076-913-02
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0367-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mercaptopurine recalls

See all